Exchange: NASDAQ·Updated 06:31 AM EDT
AZN logo

AZN AstraZeneca PLC

$159.50
$0.54
(0.34%)
Pre-Market
Prev Close $160.04
Reported EarningsJul 27
Mkt Cap$248.2B
Vol9,690.00

About AZN

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.
45

Neutral Sentiment

How do you feel about AZN?

Advertisement|Remove ads.